ADCC (antibody-dependent cell-mediated cytotoxicity) refers to antibody-dependent cell-mediated cytotoxicity. When the Fab section the antibody binds to the epitope on the surface of the target cell, its Fc section recruits effector cells (NK cells, macrophages) and binds to its surface Fc receptor (FcγR) to mediate the direct killing of the target cell by the effector cells.
The steps of ADCC are divided into four steps: antibody recognition of binding antigens, recruitment of binding effector cells, activation of effector cells, and killing target cells, and the mechanism of action of ADCC is mainly summarized into three pathways:
The cells that mediate the ADCC effect are mainly leukocytes:
Leukocyte Fraction | Effectors | Predominant Fc Receptors |
PBMC | NK cells | FcγIIIA (CD16a) |
Monocytes/macrophages | FcγI (CD64)/FcγII (CD32) | |
γδ T cell | FcγIIIA (CD16a) | |
PMN | Granulocytes (neutrophils、eosinophil、basophil) | FcγII (CD32)/FcγIIIB (CD16b) / FcαIR (CD89) |
Creative Biolabs offers a range of ADCC effector cells, click on ADCC Cell Line to view!
Creative Biolabs is a leading ADCC development technology service company, committed to providing customers with one-stop solutions. The company has a complete set of ADCC solutions, including ADCC technical services and ADCC antibody development. If you are interested, please click on the following unit ADCC Enhancement Technology and Therapeutic ADCC⁺ Biobetter Antibody Production!
Creative Biolabs provides luciferase-based ADCC assay. This Jurkat cell based assay is pioneered by Creative Biolabs, and the methodology is very well accepted by the field. See attached ADCC Reporter Assay Protocol for further details.
All products and services are for Research Use Only. Do Not use in humans.
ADCC Assay WT vs AfucoTM Mabs Visit
Antibody Fc Engineering: Towards Better Therapeutics Visit
Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.